secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2026-07-13T20:38:21+00:00
Accession:  0001628280-26-048043
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanuwave Health reports preliminary Q2 revenue $9.6-$9.8M, above guidance but down 3-5% YoY
--------------------------------------------------------------------------------

- Preliminary Q2 2026 revenue of $9.6M-$9.8M, above revised guidance of $8.5M-$9.5M but down ~3-5% from $10.1M in Q2 2025.
- Consumable applicator sales set all-time records for both unit sales and revenue, indicating growing Ultramist adoption.
- Capital sales faced headwinds from customer stress and used Ultramist systems; trade-in program for certified pre-owned units showing success.
- Results are preliminary and subject to adjustment upon completion of quarter-end close and review procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026048043/0001628280-26-048043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828026048043/snwv-20260713.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-048043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer